On this page · 9 sections
- What is sirolimus protein-bound?
- How is sirolimus protein-bound given?
- Warnings
- Before taking this medicine
- Sirolimus protein-bound side effects
- Sirolimus protein-bound dosing information
- What happens if I miss a dose?
- What happens if I overdose?
- What other drugs will affect sirolimus protein-bound?
Sirolimus protein-bound
Generic name: sirolimus protein-bound
Brand names: Fyarro
What is sirolimus protein-bound?
Sirolimus protein-bound is used to treat adults who have a specific type of perivascular epithelioid cell tumor (PEComa).
Sirolimus protein-bound may also be used for reasons that are not mentioned in this medication guide.
This section was rewritten for readability and reviewed for meaning.
How is sirolimus protein-bound given?
Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose.
Sirolimus protein-bound is injected into a vein by a healthcare professional over a 30-minute period on days 1 and 8 of each 21-day treatment cycle.
Your blood sugar will need to be checked regularly, and you may need other medical tests.
This section was rewritten for readability and reviewed for meaning.
Warnings
Both men and women using sirolimus protein-bound should use effective birth control to prevent pregnancy. Sirolimus protein-bound can harm an unborn baby if the mother or father is using this medicine.
This section was rewritten for readability and reviewed for meaning.
Before taking this medicine
You should not use sirolimus protein-bound if you are allergic to it, other rapamycin derivatives, or albumin.
Tell your doctor if you have ever had:
- liver disease;
- diabetes;
- breathing problems; or
- bleeding problems.
Both men and women taking this medicine should use effective birth control to prevent pregnancy. Sirolimus protein-bound can harm an unborn baby if the mother or father is using this medicine.
Continue using birth control for at least 12 weeks after your last dose. Tell your doctor right away if you become pregnant.
You will need to have a negative pregnancy test before starting this treatment.
Sirolimus protein-bound may affect fertility in men or women. It may be harder to achieve pregnancy while either parent is using this medicine.
Do not breastfeed while using this medicine, and for at least 2 weeks after your last dose.
This section was rewritten for readability and reviewed for meaning.
Sirolimus protein-bound side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Sirolimus protein-bound may cause serious side effects. Call your doctor immediately if you have:
- sudden chest pain, wheezing, dry cough, feeling short of breath;
- nosebleeds, bleeding gums, abnormal vaginal bleeding, any bleeding that will not stop;
- low blood potassium--leg cramps, constipation, irregular heartbeats, fluttering in your chest, increased thirst or urination, numbness or tingling, muscle weakness or limp feeling;
- signs of infection--fever, chills, sore throat, body aches, unusual tiredness, loss of appetite, bruising or bleeding; or
- low blood cell counts--fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath.
Common side effects of sirolimus protein-bound may include:
- blisters or ulcers in your mouth, red or swollen gums, trouble swallowing;
- fever, chills, sore throat, body aches, loss of appetite, bruising or bleeding;
- tiredness;
- cough;
- altered sense of taste;
- rash;
- nausea, diarrhea, vomiting;
- swelling;
- muscle, bone, or joint pain; or
- loss of weight and appetite.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
This section was rewritten for readability and reviewed for meaning.
Sirolimus protein-bound dosing information
Usual Adult Dose for Malignant perivascular epithelioid cell neoplasm:
Recommended dose: 100 mg/m2 as an IV infusion over 30 minutes on Days 1 and 8 of each 21-day cycle.Duration of therapy: Until disease progression or unacceptable toxicityUse: Adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa)
What happens if I miss a dose?
Call your doctor for guidance if you miss a dose.
This section was rewritten for readability and reviewed for meaning.
What happens if I overdose?
In a medical setting, an overdose would be treated quickly.
Avoid receiving a "live" vaccine. The vaccine may not work as well while you are using sirolimus protein-bound. Live vaccines include measles, mumps, rubella (MMR), rotavirus, typhoid, yellow fever, and varicella (chickenpox).
Grapefruit may interact with sirolimus protein-bound and cause side effects. Avoid consuming grapefruit products.
This section was rewritten for readability and reviewed for meaning.
What other drugs will affect sirolimus protein-bound?
Sometimes it is not safe to use certain medicines together. Some drugs can change the levels of other drugs in your blood, which may increase side effects or make the medicines less effective.
Other drugs may affect sirolimus protein-bound, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you are using.
This section was rewritten for readability and reviewed for meaning.
Related medicines
Content is provided for education and is not medical advice. See our medical disclaimer.